
lamisil
Pharmaranks rates Lamisil 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Lamisil (Terbinafine Hydrochloride) is an allylamine antifungal used to treat Chronic Mucocutaneous Candidiasis, Tinea Capitis, Tinea Pedis, Onychomycosis.
Terbinafine Hydrochloride · by Novartis
Available as a generic: Terbinafine Hydrochloride
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Terbinafine Hydrochloride
- Drug class
- Allylamine Antifungal
- Form
- Topical, Powder, Tablet, Solution
- Strength
- Terbinafine Hydrochloride EQ 125MG BASE/PACKET · Terbinafine Hydrochloride EQ 187.5MG BASE/PACKET
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Novartis
- What the pharmacy pays
- ~$0.14 per gm — not your price
- FDA application
- NDA022071
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
Dosage forms
Topical, Powder, Tablet and Solution
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Lamisil treat?
- Lamisil (Terbinafine Hydrochloride) may be used to treat chronic mucocutaneous candidiasis, tinea capitis, tinea pedis, onychomycosis, tinea versicolor, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Lamisil rated?
- pharmaranks gives Lamisil a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Lamisil cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $0.14 per gm, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Lamisil?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Lamisil. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Lamisil?
- Lamisil is marketed by Novartis. You can see Novartis's full profile, rating, and other products on pharmaranks.
- Is Lamisil a brand-name or generic drug?
- Lamisil is a brand-name product with the active ingredient Terbinafine Hydrochloride. Lower-cost generic equivalents containing Terbinafine Hydrochloride are available — ask your pharmacist.
- Is Lamisil available over the counter?
- No. Lamisil is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Lamisil come in?
- Lamisil is currently marketed as topical, powder, tablet and solution, per the FDA's National Drug Code Directory.
- What class of drug is Lamisil?
- Lamisil is classified as allylamine antifungal, per the FDA's Established Pharmacologic Class.
- Is Lamisil FDA-registered?
- Lamisil is on record with the U.S. FDA under application number NDA022071. You can verify this on its official FDA label.
- Has Lamisil been recalled by the FDA?
- Lamisil has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Lamisil safe?
- There's no single safe-or-not verdict. pharmaranks gives Lamisil a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Lamisil head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
lamisil
70/100